Richard A. Gonzalez, an officer at AbbVie Inc., is set to sell 66,500 shares of the company's common stock, with an aggregate market value of approximately $12.46 million, on 08/05/2024. The shares were originally acquired on 02/28/2022 as transaction performance shares from the issuer and were part of Gonzalez's executive compensation, with payment for the securities completed on 02/28/2023. This planned transaction follows a recent sale of 282,845 shares in the past three months, which grossed nearly $49.5 million.

Richard A. Gonzalez, an officer at AbbVie Inc., is set to sell 66,500 shares of the company's common stock, with an aggregate market value of approximately $12.46 million, on 08/05/2024. The shares were originally acquired on 02/28/2022 as transaction performance shares from the issuer and were part of Gonzalez's executive compensation, with payment for the securities completed on 02/28/2023. This planned transaction follows a recent sale of 282,845 shares in the past three months, which grossed nearly $49.5 million.